Molecular Cytogenetics Market - Global Opportunity Analysis, Size, Share, Growth, Trends, and Industry Forecast 2017 - 2022

LONDON, Nov. 20, 2017 (GLOBE NEWSWIRE) -- The global molecular cytogenetics market will grow at a CAGR of 11% from 2017 to 2022 to reach USD 2,266.4 million by 2022, according to the publication from Meticulous Research™. The molecular cytogenetics market is driven by increasing focus on preventive healthcare measures, growing genetic abnormalities, increasing aging population and subsequent rise in various chronic diseases, growing need to reduce mounting healthcare cost, and increasing focus on clinical and research diagnosis. Moreover, increasing focus on targeted based therapies and growing predictive and presymptomatic genetic testing further provides significant opportunities in this market. However, lack of awareness about diagnostic technologies, high cost of diagnosis, unfavourable reimbursement scenario, and technical limitations and complexities of the equipment have embraced the growth of molecular cytogenetics market globally.

The global molecular cytogenetics market is mainly segmented by technique (fluorescence in situ hybridization, comparative genomic hybridization, in situ hybridization, karyotyping, and banding techniques), by product (instruments, kits and reagents, software, services, and consumable/accessories ), by application (oncology, genetic disorders, personalized medicines, and other), and by end user (pharmaceuticals and biotechnological companies, clinical and diagnostic laboratories, and academic institutes).

Request Sample Report: http://www.meticulousresearch.com/request-sample-report/?cp_id=3067

Geographically, the global molecular cytogenetics market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounted for the major share in the global molecular cytogenetics market in 2016, followed by Europe, and Asia-Pacific region. The large share of this region is primarily attributed to the increased funding for medical research, stringent drug development regulations which demand molecular cytogenetics techniques, growing aging population and thereby prevalence of various chronic diseases, and direct & indirect financial investments in the pharma biotech companies.

The key players in the global molecular cytogenetics market are Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, Applied Spectral Imaging, Quest Diagnostics, Roche Diagnostics, Danaher Corporation, Illumina, and Oxford Gene Technology.

Full News: http://www.meticulousresearch.com/molecular-cytogenetics-market-2022/

Scope of the report

Market by Techniques

• Fluorescence In Situ Hybridization
• Comparative Genomic Hybridization (CGH)
  -- Chromosomal CGH
  -- Array-Based CGH
• In Situ Hybridization
• Karyotyping
  -- Spectral Karyotyping
  -- Virtual Karyotyping
• Banding Techniques
  -- G banding
  -- Q banding
  -- R banding
  -- C banding
  -- T banding

Market by Product

• Instruments
  -- Systems
  -- Imagers and Scanners
• Kits and Reagents
  -- Testing Kits
  -- Probes
  -- Reagents
• Software
• Services
• Consumables/Accessories

Market by Application

• Oncology
• Genetic Disorders
• Personalized Medicines
• Others

Market by End User:

• Pharmaceutical and Biotechnological companies
• Clinical and Diagnostic laboratories
• Academic Institutes
• Others

Browse in-depth Report on http://www.meticulousresearch.com/product/molecular-cytogenetics-market/

Contact Info:

Viren Shrivastava

AVP- Global Sales and Marketing

Meticulous Research™

Email: viren@meticulousresearch.com

Direct Lines: +1-646-781-8004 (North America)

+44-203-868-8738 (Europe)

+91 744-7780008 (Asia-Pacific)